Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Cortellis database update process human analysts ai?

Here’s a high-level view of how a Cortellis-style database update typically works, balancing AI automation with human curation. Note that exact internal workflows are proprietary, but these elements reflect common industry practices.

- Data sources and intake
- Ingest from diverse sources: regulatory agencies (FDA, EMA, PMDA), journals, clinical trial registries, patents, company reports, press releases, and other public/partner feeds.
- Raw data arrives in structured and unstructured formats (text, PDFs, PDFs-to-text, etc.).

- AI-driven extraction and normalization
- Natural language processing and machine learning extract entities (e.g., compounds, targets, pathways, indications, regulatory actions, trial results) and relations (drug–target interactions, mechanism of action).
- Normalization and mapping to standard ontologies/elements (e.g., CAS/InChI keys for chemicals, MeSH/UMLS terms, regulatory statuses).
- Deduplication and conflict resolution at the data-object level (e.g., same drug from multiple sources).

- Rule-based validation and quality checks
- Consistency checks (units, dosages, dates, jurisdiction-specific rules).
- Cross-source reconciliation to resolve discrepancies (e.g., conflicting trial results or regulatory statuses).

- Human curation and validation
- Subject-matter experts (SMEs) review AI-flagged data, disambiguate entities, resolve ambiguities, and add nuanced annotations (mechanisms, manufacturing forms, dose information, regulatory pathways, patent details).
- Complex interpretations, rare data types, or high-stakes entries go through expert review.

- Quality assurance (QA) and governance
- Multi-layer QA: automated tests plus manual spot checks; traceability to source documents.
- Provenance capture: each data item links back to source(s) and the update rationale.

- Integration, impact assessment, and publishing
- Updates are integrated into the existing data model, with deduplication and relationship linking to other objects (e.g., compound–target networks, trial cohorts).
- Change logs or audit trails are generated to document updates, additions, deletions, and corrections.

- Update cadence and delivery
- Continuous ingestion with automated refreshes for new/updated sources.
- Periodic “full refresh” cycles (e.g., monthly or quarterly) to refresh mappings and recalculate derived fields.
- Release notes accompany updates to highlight new entries, updated statuses, and any data corrections.

- AI model maintenance and learning
- AI models are continuously retrained on corrected and newly curated data to improve extraction accuracy.
- Human feedback loops help fine-tune models for higher precision in niche areas.

- Data governance and security
- Access controls, provenance tracking, and compliance with licensing of source data.
- Regular audits of data quality and adherence to internal standards.

If you want, I can tailor this to a specific Cortellis module (e.g., Regulatory Intelligence, Drug Discovery Intelligence, or Patent/IP data) and outline a more concrete, module-specific flow. Also, tell me what you’re most interested in (update frequency, data provenance, AI vs human roles, or how to interpret change logs) and I’ll expand that part.



Other Questions About Human :

patent landscape human milk oligosaccharides biosynthesis patent overlap Clenbuterol fda approval human use? Clenbuterol fda approval status human use? Patent landscape human milk oligosaccharides biosynthesis overlapping claims patents? Body weight effect on cosentix sc administration in human? Human insulin r price? Were human studies conducted on lurbinectedin's fetal effects?